{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:42:17Z","timestamp":1794379337491,"version":"4.9.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, the use of bacteriophages (or 'phages') against multidrug-resistant (MDR) bacteria including <jats:italic>Pseudomonas aeruginosa<\/jats:italic> has drawn considerable attention, globally. In this work, we report the isolation and detailed characterization of a highly lytic Pseudomonasphage DRL-P1 isolated from wastewater. Under TEM, DRL-P1 appeared as a member of the phage family <jats:italic>Myoviridae<\/jats:italic>. DRL-P1 featured rapid adsorption (~\u20095\u00a0min), short-latency (~\u200930\u00a0min), and large burst size (~\u2009100 PFU per infected cell). DRL-P1 can withstand a wide temperature range (4\u00a0\u00b0C to 40\u00a0\u00b0C) and pH (5.0 to 10.0) conditions. The 66,243\u00a0bp DRL-P1 genome (MN564818) encodes at least 93 ORFs, of which 36 were functionally annotated based on homology with similar phage proteins available in the databases. Comparative analyses of related genomes suggest an independent evolutionary history and discrete taxonomic position of DRL-P1 within genus <jats:italic>Pbunavirus<\/jats:italic>. No toxin or antibiotic resistance genes was identified. DRL-P1 is tolerant to lyophilization and encapsulation techniques and retained lytic activity even after 18\u00a0months of storage. We also demonstrated decontaminating potentials of DRL-P1 in vitro, on an artificially contaminated cover-slip model. To the best of our knowledge, this is the first Pbunavirus to be reported from India. Our study suggests DRL-P1 as a potential candidate for various applications.<\/jats:p>","DOI":"10.1038\/s41598-021-98457-z","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:25:07Z","timestamp":1632911107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa"],"prefix":"10.1038","volume":"11","author":[{"given":"Sonika","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibnarayan","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhuma","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan G.","family":"Vairale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjai K.","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"98457_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41579-020-0348-5","volume":"18","author":"C Nathan","year":"2020","unstructured":"Nathan, C. Resisting antimicrobial resistance. Nat. Rev. Microbiol. 18, 259\u2013260 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"98457_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"WC Reygaert","year":"2018","unstructured":"Reygaert, W. C. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 4, 482\u2013501 (2018).","journal-title":"AIMS Microbiol."},{"key":"98457_CR3","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00134-017-4878-x","volume":"43","author":"M Bassetti","year":"2017","unstructured":"Bassetti, M. et al. Antimicrobial resistance in the next 30 years, humankind, bugs, and drugs: A visionary approach. Intensive Care Med. 43, 1464\u20131475 (2017).","journal-title":"Intensive Care Med."},{"key":"98457_CR4","doi-asserted-by":"publisher","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","volume":"33","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira, D. M. P. et al. Antimicrobial resistance in ESKAPE pathogens. Clin. Microbiol. Rev. 33, e00181-19. https:\/\/doi.org\/10.1128\/CMR.00181-19 (2020).","journal-title":"Clin. Microbiol. Rev."},{"key":"98457_CR5","unstructured":"WHO. WHO Publishes List of Bacteria for Which New Antibiotics are Urgently Needed. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (2017)."},{"key":"98457_CR6","unstructured":"DBT. http:\/\/dbtindia.gov.in\/latest-announcement\/indian-priority-pathogen-list-jointly-developed-dbt-and-who-india-office (2021)."},{"key":"98457_CR7","doi-asserted-by":"publisher","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","volume":"61","author":"RT Schooley","year":"2017","unstructured":"Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61, e00954-e1017 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"98457_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jpids\/pix056","volume":"7","author":"C Duplessis","year":"2018","unstructured":"Duplessis, C. et al. Refractory Pseudomonas bacteremia in a 2-year-old sterilized by bacteriophage therapy. J. Pediatric. Infect. Dis. Soc. 7, 253\u2013256 (2018).","journal-title":"J. Pediatric. Infect. Dis. Soc."},{"key":"98457_CR9","doi-asserted-by":"publisher","first-page":"608402","DOI":"10.3389\/fcimb.2020.608402","volume":"10","author":"J Qin","year":"2021","unstructured":"Qin, J. et al. Heterogeneous Klebsiella pneumoniae co-infections complicate personalized bacteriophage therapy. Front. Cell. Infect. Microbiol. 10, 608402. https:\/\/doi.org\/10.3389\/fcimb.2020.608402 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"98457_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","volume":"5","author":"A Petrovic Fabijan","year":"2020","unstructured":"Petrovic Fabijan, A. et al. Westmead Bacteriophage Therapy Team. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat. Microbiol. 5, 465\u2013472 (2020).","journal-title":"Nat. Microbiol."},{"key":"98457_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14787210.2021.1858800","volume":"19","author":"A Patil","year":"2021","unstructured":"Patil, A., Banerji, R., Kanojiya, P., Koratkar, S. & Saroj, S. Bacteriophages for ESKAPE: Role in pathogenicity and measures of control. Expert. Rev. Anti. Infect. Ther. 19, 845\u2013865 (2021).","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"98457_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cid\/ciy947","volume":"69","author":"L El Haddad","year":"2019","unstructured":"El Haddad, L., Harb, C. P., Gebara, M. A., Stibich, M. A. & Chemaly, R. F. A Systematic and critical review of bacteriophage therapy against multidrug-resistant ESKAPE organisms in Humans. Clin. Infect. Dis. 69, 167\u2013178 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"98457_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S. & Pardesi, K. R. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A Review. Front. Microbiol. 10, 539. https:\/\/doi.org\/10.3389\/fmicb.2019.00539 (2019).","journal-title":"Front. Microbiol."},{"key":"98457_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1099\/mic.0.000860","volume":"166","author":"SP Diggle","year":"2020","unstructured":"Diggle, S. P. & Whiteley, M. Microbe Profile: Pseudomonas aeruginosa: Opportunistic pathogen and lab rat. Microbiology (Reading) 166, 30\u201333 (2020).","journal-title":"Microbiology (Reading)"},{"key":"98457_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fmicb.2019.00913","volume":"10","author":"O Ciofu","year":"2019","unstructured":"Ciofu, O. & Tolker-Nielsen, T. Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents: How P aeruginosa can escape antibiotics. Front. Microbiol. 10, 913. https:\/\/doi.org\/10.3389\/fmicb.2019.00913 (2019).","journal-title":"Front. Microbiol."},{"key":"98457_CR16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.bpj.2011.02.020","volume":"100","author":"JC Conrad","year":"2011","unstructured":"Conrad, J. C. et al. Flagella and pili-mediated near-surface single-cell motility mechanisms in P. aeruginosa. Biophys. J. 100, 1608\u20131616 (2011).","journal-title":"Biophys. J."},{"key":"98457_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev-micro-092611-150055","volume":"66","author":"LL Burrows","year":"2012","unstructured":"Burrows, L. L. Pseudomonas aeruginosa twitching motility: Type IV pili in action. Annu. Rev. Microbiol. 66, 493\u2013520 (2012).","journal-title":"Annu. Rev. Microbiol."},{"key":"98457_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11783-020-1378-y","volume":"15","author":"M Ji","year":"2021","unstructured":"Ji, M. et al. Bacteriophages in water pollution control: Advantages and limitations. Front. Environ. Sci. Eng. 15, 84. https:\/\/doi.org\/10.1007\/s11783-020-1378-y (2021).","journal-title":"Front. Environ. Sci. Eng."},{"key":"98457_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00284-011-0071-6","volume":"64","author":"S Ahiwale","year":"2012","unstructured":"Ahiwale, S. et al. BVPaP-3, a T7-like lytic phage of Pseudomonas aeruginosa: Its isolation and characterisation. Curr. Microbiol. 64, 305\u2013311 (2012).","journal-title":"Curr. Microbiol."},{"key":"98457_CR20","doi-asserted-by":"publisher","first-page":"e0179245","DOI":"10.1371\/journal.pone.0179245","volume":"12","author":"RR Pallavali","year":"2017","unstructured":"Pallavali, R. R., Degati, V. L., Lomada, D., Reddy, M. C. & Durbaka, V. R. P. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections. PLoS ONE 12, e0179245. https:\/\/doi.org\/10.1371\/journal.pone.0179245 (2017).","journal-title":"PLoS ONE"},{"key":"98457_CR21","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1099\/mic.0.000104","volume":"161","author":"S Chhibber","year":"2015","unstructured":"Chhibber, S., Bansal, S. & Kaur, S. Disrupting the mixed-species biofilm of Klebsiella pneumoniae B5055 and Pseudomonas aeruginosa PAO using bacteriophages alone or in combination with xylitol. Microbiology 161, 1369\u20131377 (2015).","journal-title":"Microbiology"},{"key":"98457_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1534734619835115","volume":"18","author":"P Gupta","year":"2019","unstructured":"Gupta, P., Singh, H. S., Shukla, V. K., Nath, G. & Bhartiya, S. K. Bacteriophage therapy of chronic nonhealing wound: Clinical study. Int. J. Low. Extrem. Wounds. 18, 171\u2013175 (2019).","journal-title":"Int. J. Low. Extrem. Wounds."},{"key":"98457_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1746-6148-9-264","volume":"9","author":"K Khairnar","year":"2013","unstructured":"Khairnar, K., Raut, M. P., Chandekar, R. H., Sanmukh, S. G. & Paunikar, W. N. Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish. BMC Vet. Res. 9, 264. https:\/\/doi.org\/10.1186\/1746-6148-9-264 (2013).","journal-title":"BMC Vet. Res."},{"key":"98457_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/0377-4929.42511","volume":"51","author":"CS Vinodkumar","year":"2008","unstructured":"Vinodkumar, C. S., Kalsurmath, S. & Neelagund, Y. F. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Indian. J. Pathol. Microbiol. 51, 360\u2013366 (2008).","journal-title":"Indian. J. Pathol. Microbiol."},{"key":"98457_CR25","first-page":"16","volume":"61","author":"S Basu","year":"2015","unstructured":"Basu, S., Agarwal, M., Bhartiya, S. K., Nath, G. & Shukla, V. K. An In vivo wound model utilizing bacteriophage therapy of Pseudomonas aeruginosa biofilms. Ostomy. Wound. Manage. 61, 16\u201323 (2015).","journal-title":"Ostomy. Wound. Manage."},{"key":"98457_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/antibiotics8030126","volume":"8","author":"L Fern\u00e1ndez","year":"2019","unstructured":"Fern\u00e1ndez, L., Guti\u00e9rrez, D., Garc\u00eda, P. & Rodr\u00edguez, A. The perfect bacteriophage for therapeutic applications: A quick guide. Antibiotics 8, 126. https:\/\/doi.org\/10.3390\/antibiotics8030126 (2019).","journal-title":"Antibiotics"},{"key":"98457_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/0974-2727.208261","volume":"9","author":"P Batra","year":"2017","unstructured":"Batra, P., Deo, V., Mathur, P. & Gupta, A. K. Cotrimoxazole, a wonder drug in the era of multi resistance: Case report and review of literature. J. Lab. Physicians 9, 210\u2013213 (2017).","journal-title":"J. Lab. Physicians"},{"key":"98457_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11274-016-2009-4","volume":"32","author":"AM Motlagh","year":"2016","unstructured":"Motlagh, A. M., Bhattacharjee, A. S. & Goel, R. Biofilm control with natural and genetically-modified phages. World J. Microb. Biot. 32, 67 (2016).","journal-title":"World J. Microb. Biot."},{"key":"98457_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/emph\/eoy005","volume":"2018","author":"BK Chan","year":"2018","unstructured":"Chan, B. K. et al. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol. Med. Public. Health 2018, 60\u201366. https:\/\/doi.org\/10.1093\/emph\/eoy005 (2018).","journal-title":"Evol. Med. Public. Health"},{"key":"98457_CR30","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1099\/jmm.0.029744-0","volume":"60","author":"A Khawaldeh","year":"2011","unstructured":"Khawaldeh, A. et al. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. J. Med. Microbiol. 60, 1697\u20131700 (2011).","journal-title":"J. Med. Microbiol."},{"key":"98457_CR31","doi-asserted-by":"publisher","first-page":"e01215","DOI":"10.1128\/mSphere.01215-20","volume":"6","author":"ND Menon","year":"2021","unstructured":"Menon, N. D. et al. A Novel N4-Like Bacteriophage isolated from a wastewater source in South India with activity against several multidrug-resistant clinical Pseudomonas aeruginosa isolates. mSphere 6, e01215. https:\/\/doi.org\/10.1128\/mSphere.01215-20 (2021).","journal-title":"mSphere"},{"key":"98457_CR32","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3389\/fmicb.2017.01355","volume":"8","author":"L Amarillas","year":"2017","unstructured":"Amarillas, L. et al. Isolation and characterization of phiLLS, a novel phage with potential biocontrol agent against multidrug-resistant Escherichia coli. Front. Microbial. 8, 1355 (2017).","journal-title":"Front. Microbial."},{"key":"98457_CR33","first-page":"37","volume":"28","author":"M Yazdi","year":"2018","unstructured":"Yazdi, M., Bouzari, M. & Ghaemi, E. A. Isolation and characterization of a lytic bacteriophage (vB_PmiS-TH) and its application in combination with ampicillin against planktonic and biofilm forms of Proteus mirabilis isolated from urinary tract infection. J. Mol. Microbiol. Biotechnol. 28, 37\u201346 (2018).","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"98457_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ph12010035","volume":"12","author":"P Hyman","year":"2019","unstructured":"Hyman, P. Phages for phage therapy: Isolation, characterization, and host range breadth. Pharmaceuticals 12, 35. https:\/\/doi.org\/10.3390\/ph12010035 (2019).","journal-title":"Pharmaceuticals"},{"key":"98457_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11274-016-2028-1","volume":"32","author":"SA Jassim","year":"2016","unstructured":"Jassim, S. A., Limoges, R. G. & El-Cheikh, H. Bacteriophage biocontrol in wastewater treatment. World. J. Microbiol. Biotechnol. 32, 70. https:\/\/doi.org\/10.1007\/s11274-016-2028-1 (2016).","journal-title":"World. J. Microbiol. Biotechnol."},{"key":"98457_CR36","unstructured":"Pbunavirus. https:\/\/viralzone.expasy.org\/2818?outline=all_by_species."},{"key":"98457_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/molbev\/msj030","volume":"23","author":"DH Huson","year":"2006","unstructured":"Huson, D. H. & Bryant, D. Application of phylogenetic networks in evolutionary studies. Mol. Biol. Evol. 23, 254\u2013267 (2006).","journal-title":"Mol. Biol. Evol."},{"key":"98457_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.coviro.2011.06.009","volume":"1","author":"GF Hatfull","year":"2011","unstructured":"Hatfull, G. F. & Hendrix, R. W. Bacteriophages and their genomes. Curr. Opin. Virol. 1, 298\u2013303 (2011).","journal-title":"Curr. Opin. Virol."},{"key":"98457_CR39","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1128\/AEM.02677-10","volume":"77","author":"C O'May","year":"2011","unstructured":"O\u2019May, C. & Tufenkji, N. The swarming motility of Pseudomonas aeruginosa is blocked by cranberry pro anthocyanidins and other tannin-containing materials. Appl. Environ. Microbiol. 77, 3061\u20133067 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"98457_CR40","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1128\/JB.01620-07","volume":"190","author":"TS Murray","year":"2008","unstructured":"Murray, T. S. & Kazmierczak, B. I. Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella. J. Bacteriol. 190, 2700\u20132708 (2008).","journal-title":"J. Bacteriol."},{"key":"98457_CR41","doi-asserted-by":"publisher","first-page":"e1008444","DOI":"10.1371\/journal.ppat.1008444","volume":"16","author":"D Pletzer","year":"2020","unstructured":"Pletzer, D. et al. Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58. PLoS. Pathog. 16, e1008444. https:\/\/doi.org\/10.1371\/journal.ppat.1008444 (2020).","journal-title":"PLoS. Pathog."},{"key":"98457_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhin.2004.03.022","volume":"57","author":"C Defez","year":"2004","unstructured":"Defez, C. et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J. Hosp. Infect. 57, 209\u2013216 (2004).","journal-title":"J. Hosp. Infect."},{"key":"98457_CR43","doi-asserted-by":"publisher","first-page":"e0131714","DOI":"10.1371\/journal.pone.0131714","volume":"10","author":"KC Jensen","year":"2015","unstructured":"Jensen, K. C. et al. Isolation and host range of bacteriophage with lytic activity against methicillin-resistant Staphylococcus aureus and potential use as a fomites decontaminant. PLoS ONE 10, e0131714 (2015).","journal-title":"PLoS ONE"},{"key":"98457_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4161\/bact.22240","volume":"2","author":"MH Rashid","year":"2012","unstructured":"Rashid, M. H. et al. A Yersinia pestis-specific, lytic phage preparation significantly reduces viable Y. pestis on various hard surfaces experimentally contaminated with the bacterium. Bacteriophage. 2, 168\u2013177 (2012).","journal-title":"Bacteriophage."},{"key":"98457_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1128\/AEM.01797-10","volume":"77","author":"MK Kay","year":"2011","unstructured":"Kay, M. K., Erwin, T. C., McLean, R. J. & Aron, G. M. Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities. Appl. Environ. Microbiol. 77, 821\u2013829 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"98457_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep28115","volume":"6","author":"K Danis-Wlodarczyk","year":"2016","unstructured":"Danis-Wlodarczyk, K. et al. A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections. Sci. Rep. 6, 1\u201313 (2016).","journal-title":"Sci. Rep."},{"key":"98457_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1128\/AAC.00669-09","volume":"54","author":"W Fu","year":"2010","unstructured":"Fu, W. et al. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54, 397\u2013404 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"98457_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","volume":"19","author":"Z Chegini","year":"2020","unstructured":"Chegini, Z. et al. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: A review. Ann. Clin. Microbiol. Antimicrob. 19, 45. https:\/\/doi.org\/10.1186\/s12941-020-00389-5 (2020).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"98457_CR49","doi-asserted-by":"publisher","first-page":"580779","DOI":"10.3389\/fmicb.2020.580779","volume":"11","author":"VC Oliveira","year":"2020","unstructured":"Oliveira, V. C. et al. Identification and characterization of new bacteriophages to control multidrug-resistant Pseudomonas aeruginosa biofilm on endotracheal tubes. Front. Microbiol. 11, 580779. https:\/\/doi.org\/10.3389\/fmicb.2020.580779 (2020).","journal-title":"Front. Microbiol."},{"key":"98457_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-51742-4","volume":"9","author":"P Manohar","year":"2019","unstructured":"Manohar, P. & Ramesh, N. Improved lyophilization conditions for long-term storage of bacteriophages. Sci. Rep. 9, 1\u201310 (2019).","journal-title":"Sci. Rep."},{"key":"98457_CR51","doi-asserted-by":"publisher","first-page":"675440","DOI":"10.3389\/fphar.2021.675440","volume":"12","author":"VS Gondil","year":"2021","unstructured":"Gondil, V. S. & Chhibber, S. Bacteriophage and endolysin encapsulation systems: A promising strategy to improve therapeutic outcomes. Front. Pharmacol. 12, 675440. https:\/\/doi.org\/10.3389\/fphar.2021.675440 (2021).","journal-title":"Front. Pharmacol."},{"key":"98457_CR52","doi-asserted-by":"publisher","first-page":"41441","DOI":"10.1038\/srep41441","volume":"7","author":"J Colom","year":"2017","unstructured":"Colom, J. et al. Microencapsulation with alginate\/CaCO3: A strategy for improved phage therapy. Sci. Rep. 7, 41441. https:\/\/doi.org\/10.1038\/srep41441 (2017).","journal-title":"Sci. Rep."},{"key":"98457_CR53","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.mimet.2011.01.007","volume":"84","author":"P Golec","year":"2011","unstructured":"Golec, P. et al. A reliable method for storage of tailed phages. J. Microbiol. Methods. 84, 486\u2013489 (2011).","journal-title":"J. Microbiol. Methods."},{"key":"98457_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/microorganisms8020282","volume":"8","author":"L Liang","year":"2020","unstructured":"Liang, L. et al. Development of a lyophilization process for campylobacter bacteriophage storage and transport. Microorganisms. 8, 282 (2020).","journal-title":"Microorganisms."},{"key":"98457_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/21691401.2016.1153485","volume":"45","author":"F Moghtader","year":"2017","unstructured":"Moghtader, F., E\u011fri, S. & Piskin, E. Phages in modified alginate beads. Artif. Cells Nanomed. Biotechnol. 45, 357\u2013363 (2017).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"98457_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13568-019-0810-9","volume":"9","author":"AS Abdelsattar","year":"2019","unstructured":"Abdelsattar, A. S., Abdelrahman, F., Dawoud, A., Connerton, I. F. & El-Shibiny, A. Encapsulation of E. coli phage ZCEC5 in chitosan-alginate beads as a delivery system in phage therapy. AMB Express 9, 87. https:\/\/doi.org\/10.1186\/s13568-019-0810-9 (2019).","journal-title":"AMB Express"},{"key":"98457_CR57","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fmicb.2018.00775","volume":"9","author":"M Rossitto","year":"2018","unstructured":"Rossitto, M., Fiscarelli, E. V. & Rosati, P. Challenges and promises for planning future clinical research into bacteriophage therapy against Pseudomonas aeruginosa in cystic fibrosis. An argumentative review. Front. Microbiol. 9, 775. https:\/\/doi.org\/10.3389\/fmicb.2018.00775 (2018).","journal-title":"Front. Microbiol."},{"key":"98457_CR58","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1007\/s00253-017-8504-1","volume":"101","author":"JR Shiley","year":"2017","unstructured":"Shiley, J. R., Comfort, K. K. & Robinson, J. B. Immunogenicity and antimicrobial effectiveness of Pseudomonas aeruginosa specific bacteriophage in a human lung in vitro model. Appl. Microbiol. Biotechnol. 101, 7977\u20137985 (2017).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"98457_CR59","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3389\/fmicb.2016.01631","volume":"7","author":"V Krylov","year":"2016","unstructured":"Krylov, V. et al. Modular approach to select bacteriophages targeting Pseudomonas aeruginosa for their application to children suffering with cystic fibrosis. Front. Microbiol. 7, 1631. https:\/\/doi.org\/10.3389\/fmicb.2016.01631 (2016).","journal-title":"Front. Microbiol."},{"key":"98457_CR60","first-page":"1","volume-title":"Molecular Cloning, A Laboratory Manual","author":"JR Sambrook","year":"2001","unstructured":"Sambrook, J. R. & Russell, D. W. In Molecular Cloning, A Laboratory Manual (eds Sambrook, J. R. & Russell, D. W.) 1\u2013117 (Cold Spring Harbor Laboratory Press, 2001)."},{"key":"98457_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"C Schneider","year":"2012","unstructured":"Schneider, C., Rasband, W. & Eliceiri, K. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 9, 671\u2013675 (2012).","journal-title":"Nat. Methods."},{"key":"98457_CR62","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100\u2013S24","author":"PA Wayne","year":"2014","unstructured":"Wayne, P. A. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100\u2013S24 (Clinical and Laboratory Standards Institute, 2014)."},{"key":"98457_CR63","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1038\/s41598-019-42681-1","volume":"9","author":"SG Kim","year":"2019","unstructured":"Kim, S. G. et al. Isolation and characterisation of pVa-21, a giant bacteriophage with anti-biofilm potential against Vibrio alginolyticus. Sci. Rep. 9, 6284. https:\/\/doi.org\/10.1038\/s41598-019-42681-1 (2019).","journal-title":"Sci. Rep."},{"key":"98457_CR64","doi-asserted-by":"publisher","first-page":"7013236","DOI":"10.1155\/2017\/7013236","volume":"2017","author":"PK Litt","year":"2017","unstructured":"Litt, P. K. & Jaroni, D. Isolation and physio-morphological characterization of Escherichia coli O157: H7-infecting bacteriophages recovered from beef cattle operations. Int. J. Microbiol. 2017, 7013236. https:\/\/doi.org\/10.1155\/2017\/7013236 (2017).","journal-title":"Int. J. Microbiol."},{"key":"98457_CR65","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/bioinformatics\/btv120","volume":"31","author":"M Hunt","year":"2015","unstructured":"Hunt, M. et al. IVA: Accurate de novo assembly of RNA virus genomes. J. Bioinform. 31, 2374\u20132376 (2015).","journal-title":"J. Bioinform."},{"key":"98457_CR66","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/nar\/29.12.2607","volume":"29","author":"J Besemer","year":"2001","unstructured":"Besemer, J., Lomsadze, A. & Borodovsky, M. GeneMarks: A self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res. 29, 2607\u20132618 (2001).","journal-title":"Nucleic Acids Res."},{"key":"98457_CR67","doi-asserted-by":"publisher","first-page":"W16","DOI":"10.1093\/nar\/gkw387","volume":"44","author":"D Arndt","year":"2016","unstructured":"Arndt, D. et al. PHASTER: A better, faster version of the PHAST phage search tool. Nucleic Acids Res. 44, W16\u2013W21. https:\/\/doi.org\/10.1093\/nar\/gkw387 (2016).","journal-title":"Nucleic Acids Res."},{"key":"98457_CR68","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul, S. F. et al. Basic local alignment search tool. J Mol. Biol. 215, 403\u2013410 (1990).","journal-title":"J Mol. Biol."},{"key":"98457_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9173-0_1","volume":"1962","author":"PP Chan","year":"2019","unstructured":"Chan, P. P. & Lowe, T. M. tRNAscan-SE: Searching for tRNA genes in genomic sequences. Methods Mol. Biol. 1962, 1\u201314 (2019).","journal-title":"Methods Mol. Biol."},{"key":"98457_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0097-8485(01)00099-7","volume":"26","author":"MG Reese","year":"2001","unstructured":"Reese, M. G. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput. Chem. 26, 51\u201356 (2001).","journal-title":"Comput. Chem."},{"key":"98457_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4161\/rna.8.1.13346","volume":"8","author":"M Naville","year":"2011","unstructured":"Naville, M., Ghuillot-Gaudeffroy, A., Marchais, A. & Gautheret, D. ARNold: A web tool for the prediction of Rho-independent transcription terminators. RNA Biol. 8, 11\u201313. https:\/\/doi.org\/10.4161\/rna.8.1.13346 (2011).","journal-title":"RNA Biol."},{"key":"98457_CR72","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/bioinformatics\/bts014","volume":"28","author":"K McNair","year":"2012","unstructured":"McNair, K., Bailey, B. A. & Edwards, R. A. PHACTS, a computational approach to classifying the lifestyle of phages. J. Bioinform. 28, 614\u2013618 (2012).","journal-title":"J. Bioinform."},{"key":"98457_CR73","doi-asserted-by":"crossref","first-page":"D517","DOI":"10.1093\/nar\/gkz1136","volume":"48","author":"BP Alcock","year":"2020","unstructured":"Alcock, B. P. et al. CARD 2020: Antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48, D517\u2013D525 (2020).","journal-title":"Nucleic Acids Res."},{"key":"98457_CR74","doi-asserted-by":"publisher","first-page":"D61","DOI":"10.1093\/nar\/gkl842","volume":"35","author":"KD Pruitt","year":"2007","unstructured":"Pruitt, K. D., Tatusova, T. & Maglott, D. R. NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 35, D61\u2013D65 (2007).","journal-title":"Nucleic Acids Res."},{"key":"98457_CR75","first-page":"95","volume":"41","author":"TA Hall","year":"1999","unstructured":"Hall, T. A. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symp. Ser. 41, 95\u201398 (1999).","journal-title":"Nucleic Acids Symp. Ser."},{"key":"98457_CR76","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkf436","volume":"30","author":"K Katoh","year":"2002","unstructured":"Katoh, K., Misawa, K., Kuma, K. I. & Miyata, T. MAFFT: A novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 30, 3059\u20133066 (2002).","journal-title":"Nucleic Acids Res."},{"key":"98457_CR77","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547\u20131549 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"98457_CR78","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/v12111268","volume":"12","author":"C Moraru","year":"2020","unstructured":"Moraru, C., Varsani, A. & Kropinski, A. M. VIRIDIC: A novel tool to calculate the intergenomic similarities of prokaryote-infecting viruses. Viruses 12, 1268 (2020).","journal-title":"Viruses"},{"key":"98457_CR79","doi-asserted-by":"publisher","first-page":"e11147","DOI":"10.1371\/journal.pone.0011147","volume":"5","author":"AE Darling","year":"2010","unstructured":"Darling, A. E., Mau, B. & Perna, N. T. progressiveMauve: Multiple genome alignment with gene gain Loss and rearrangement. PLoS ONE 5, e11147. https:\/\/doi.org\/10.1371\/journal.pone.0011147 (2010).","journal-title":"PLoS ONE"},{"key":"98457_CR80","doi-asserted-by":"publisher","first-page":"vev003","DOI":"10.1093\/ve\/vev003","volume":"1","author":"DP Martin","year":"2015","unstructured":"Martin, D. P., Murrell, B., Golden, M., Khoosal, A. & Muhire, B. RDP4: Detection and analysis of recombination patterns in virus genomes. Virus Evol. 1, vev003. https:\/\/doi.org\/10.1093\/ve\/vev003 (2015).","journal-title":"Virus Evol."},{"key":"98457_CR81","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1038\/s41598-020-62691-8","volume":"10","author":"M Horv\u00e1th","year":"2020","unstructured":"Horv\u00e1th, M. et al. Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates. Sci. Rep. 10, 5891. https:\/\/doi.org\/10.1038\/s41598-020-62691-8 (2020).","journal-title":"Sci. Rep."},{"key":"98457_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12866-020-01811-w","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu, J., Gao, S., Dong, Y., Lu, C. & Liu, Y. Isolation and characterization of bacteriophages against virulent Aeromonas hydrophila. BMC Microbiol. 20, 141. https:\/\/doi.org\/10.1186\/s12866-020-01811-w (2020).","journal-title":"BMC Microbiol."},{"key":"98457_CR83","doi-asserted-by":"publisher","first-page":"e0205728","DOI":"10.1371\/journal.pone.0205728","volume":"13","author":"E Gonzalez-Menendez","year":"2018","unstructured":"Gonzalez-Menendez, E. et al. Comparative analysis of different preservation techniques for the storage of Staphylococcus phages aimed for the industrial development of phage-based antimicrobial products. PLoS ONE 13, e0205728. https:\/\/doi.org\/10.1371\/journal.pone.0205728 (2018).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98457-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T22:05:00Z","timestamp":1675721100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98457-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98457"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98457-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19393"}}